Finance

Beta
Lists
IJF:FRA
ICON PLC
€145.60
-1.75%
(-2.60) 1D
Jul 17, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for IJF...
Open
€145.60
High
€145.60
Low
€145.60
Mkt. cap
13.02B
Avg. vol.
6.00
Volume
0.00
52-wk high
€170.30
52-wk low
€66.26
No. of employees
40K
Open
€145.60
High
€145.60
Low
€145.60
Mkt. cap
13.02B
Avg. vol.
6.00
Volume
0.00
52-wk high
€170.30
52-wk low
€66.26
No. of employees
40K
News stories
From sources across the web
Profile
Icon plc is an Irish-headquartered multinational clinical research organisation. Icon conducts clinical trials on behalf of pharmaceutical and biotechnology companies and provides services related to drug development and guiding clinical trial progress. As of December 2025 Icon had approximately 40,100 employees in 55 countries. Wikipedia
About ICON PLC
CEOBarry Balfe
Employees40.4K
Founded1990
Headquarters-
SectorHealth care
Websiteiconplc.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
2.02B
2.04B
2.19B
2.03B
Cost of goods sold
1.46B
1.49B
1.69B
1.55B
Cost of revenue
1.46B
1.49B
1.69B
1.55B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
205.01M
198.75M
-605.04M
202.30M
Operating expense
302.72M
297.24M
850.77M
292.63M
Total operating expenses
1.76B
1.78B
2.54B
1.85B
Operating income
258.88M
258.90M
-355.01M
187.00M
Other non operating income
-
-
-9.38M
-
EBT including unusual items
161.11M
38.10M
-142.45M
127.56M
EBT excluding unusual items
210.78M
210.42M
-409.19M
140.82M
Income tax expense
-21.86M
35.75M
-17.01M
22.81M
Effective tax rate
-13.57%
93.82%
11.94%
17.88%
Other operating expenses
-
-
1.70B
-
Net income
182.97M
2.36M
-125.44M
104.75M
Net profit margin
9.07%
0.12%
-5.73%
5.15%
Earnings per share
3.26
3.31
2.52
2.50
Interest and investment income
2.05M
1.76M
1.49M
1.82M
Interest expense
-50.15M
-50.24M
-46.29M
-48.00M
Net interest expenses
-48.10M
-48.48M
-44.80M
-46.18M
Depreciation and amortization charges
97.72M
98.50M
-292.17M
90.33M
EBITDA
356.59M
357.40M
-264.19M
277.33M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer